Collaborating to implement evidence-based interventions in vulnerable groups and marginalised communities
More than six million Australians suffer from chronic liver diseases, costing the nation more than $50 billion a year in health care costs and lost productivity
Sydney Health Partners’ Liver collaborative network is researching the scale-up of novel, evidence-based, interventions and their application in community and marginalised settings.
Focusing on the elimination of hepatitis C using Direct Acting Antivirals, the collaboration is enhancing sector capability, reducing clinical variation, developing platforms for data integration, increasing consumer engagement and closing the loop between health practice and research.
Professor Jacob George
Chair of Hepatic Medicine, Sydney Medical School – University of SydneyVisit Profile of Professor Jacob George
Director, Storr Liver Centre - The Westmead Institute for Medical Research
Head, Department of Gastroenterology & Hepatology - Western Sydney Local Health District
The best way to get involved with Sydney Health Partners Liver collaborative is to contact the network lead directly.